

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.60499050 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.60499050 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.60499050 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.60499050 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.60499050 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.60499050 |
| 7 | microglial cell activation (GO:0001774) | 6.33327271 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 5.78620572 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.46565607 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.88240087 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 4.76255302 |
| 12 | barbed-end actin filament capping (GO:0051016) | 4.69995419 |
| 13 | protein localization to endosome (GO:0036010) | 4.57488687 |
| 14 | regulation of interferon-alpha production (GO:0032647) | 4.56635597 |
| 15 | macrophage activation (GO:0042116) | 4.34806173 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 4.21974152 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 4.21974152 |
| 18 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.20415300 |
| 19 | response to host (GO:0075136) | 4.20415300 |
| 20 | response to host defenses (GO:0052200) | 4.20415300 |
| 21 | response to host immune response (GO:0052572) | 4.17981556 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17981556 |
| 23 | response to peptidoglycan (GO:0032494) | 4.12686033 |
| 24 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.94960021 |
| 25 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.91031591 |
| 26 | glycolipid catabolic process (GO:0019377) | 3.90249461 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 3.88301813 |
| 28 | hemidesmosome assembly (GO:0031581) | 3.85651007 |
| 29 | I-kappaB phosphorylation (GO:0007252) | 3.81917770 |
| 30 | epithelial cell-cell adhesion (GO:0090136) | 3.79702668 |
| 31 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.66314784 |
| 32 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.58136408 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.57431365 |
| 34 | skin morphogenesis (GO:0043589) | 3.55272132 |
| 35 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.55112755 |
| 36 | oligosaccharide catabolic process (GO:0009313) | 3.51376121 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.48955551 |
| 38 | cell adhesion mediated by integrin (GO:0033627) | 3.47896147 |
| 39 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.47894206 |
| 40 | positive regulation of chemokine secretion (GO:0090197) | 3.46787328 |
| 41 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.40130599 |
| 42 | regulation of early endosome to late endosome transport (GO:2000641) | 3.39319611 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.37219988 |
| 44 | ceramide catabolic process (GO:0046514) | 3.32121214 |
| 45 | apoptotic cell clearance (GO:0043277) | 3.31103017 |
| 46 | positive regulation of interferon-beta production (GO:0032728) | 3.30216331 |
| 47 | stress fiber assembly (GO:0043149) | 3.29754759 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.20534195 |
| 49 | cell-substrate junction assembly (GO:0007044) | 3.15824445 |
| 50 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.14524655 |
| 51 | protein retention in ER lumen (GO:0006621) | 3.13620866 |
| 52 | adhesion of symbiont to host (GO:0044406) | 3.12748186 |
| 53 | hyaluronan catabolic process (GO:0030214) | 3.10597942 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09839690 |
| 55 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.08908197 |
| 56 | immunoglobulin mediated immune response (GO:0016064) | 3.08686804 |
| 57 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.07611328 |
| 58 | regulation of mononuclear cell migration (GO:0071675) | 3.06237368 |
| 59 | pinocytosis (GO:0006907) | 3.05980664 |
| 60 | semaphorin-plexin signaling pathway (GO:0071526) | 3.05654616 |
| 61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03063310 |
| 62 | adhesion of symbiont to host cell (GO:0044650) | 3.02806860 |
| 63 | virion attachment to host cell (GO:0019062) | 3.02806860 |
| 64 | endodermal cell differentiation (GO:0035987) | 3.01978855 |
| 65 | regulation of chemokine secretion (GO:0090196) | 3.00346390 |
| 66 | basement membrane organization (GO:0071711) | 2.99918844 |
| 67 | wound healing, spreading of epidermal cells (GO:0035313) | 2.99384438 |
| 68 | desmosome organization (GO:0002934) | 2.98733887 |
| 69 | negative regulation of granulocyte differentiation (GO:0030853) | 2.98551952 |
| 70 | detection of molecule of bacterial origin (GO:0032490) | 2.98139160 |
| 71 | regulation of antigen processing and presentation (GO:0002577) | 2.95686649 |
| 72 | respiratory burst (GO:0045730) | 2.94668223 |
| 73 | positive regulation of receptor recycling (GO:0001921) | 2.92418085 |
| 74 | amino sugar catabolic process (GO:0046348) | 2.91414779 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91037858 |
| 76 | phagocytosis, engulfment (GO:0006911) | 2.90322446 |
| 77 | positive regulation of macrophage cytokine production (GO:0060907) | 2.86627220 |
| 78 | adherens junction assembly (GO:0034333) | 2.86515487 |
| 79 | granulocyte activation (GO:0036230) | 2.83669443 |
| 80 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.83462906 |
| 81 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.83053929 |
| 82 | glial cell migration (GO:0008347) | 2.82388315 |
| 83 | cellular extravasation (GO:0045123) | 2.79618924 |
| 84 | cortical actin cytoskeleton organization (GO:0030866) | 2.78625716 |
| 85 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.77766345 |
| 86 | membrane lipid catabolic process (GO:0046466) | 2.76961722 |
| 87 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.76664439 |
| 88 | positive regulation of chemokine production (GO:0032722) | 2.76648998 |
| 89 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.75999775 |
| 90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75872391 |
| 91 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.75494729 |
| 92 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.73777303 |
| 93 | mannose metabolic process (GO:0006013) | 2.73037361 |
| 94 | neutrophil activation (GO:0042119) | 2.73001784 |
| 95 | response to thyroid hormone (GO:0097066) | 2.72422082 |
| 96 | response to laminar fluid shear stress (GO:0034616) | 2.71511724 |
| 97 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.70379356 |
| 98 | osteoclast differentiation (GO:0030316) | 2.70163045 |
| 99 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.69435745 |
| 100 | sphingolipid catabolic process (GO:0030149) | 2.69251438 |
| 101 | regulation of monocyte chemotaxis (GO:0090025) | 2.69101769 |
| 102 | membrane protein ectodomain proteolysis (GO:0006509) | 2.69069743 |
| 103 | keratan sulfate catabolic process (GO:0042340) | 2.68706055 |
| 104 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.68099010 |
| 105 | regulation of macrophage chemotaxis (GO:0010758) | 2.67151478 |
| 106 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.66854813 |
| 107 | endothelial cell chemotaxis (GO:0035767) | 2.65130735 |
| 108 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.64689516 |
| 109 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.64589169 |
| 110 | cytokine secretion (GO:0050663) | 2.63954460 |
| 111 | regulation of integrin activation (GO:0033623) | 2.63606112 |
| 112 | positive regulation of leukocyte degranulation (GO:0043302) | 2.62897948 |
| 113 | low-density lipoprotein particle clearance (GO:0034383) | 2.62717062 |
| 114 | peptide catabolic process (GO:0043171) | 2.61719228 |
| 115 | surfactant homeostasis (GO:0043129) | 2.61717645 |
| 116 | decidualization (GO:0046697) | 2.61425877 |
| 117 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.60698466 |
| 118 | substrate-dependent cell migration (GO:0006929) | 2.60067614 |
| 119 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.59748607 |
| 120 | glycosphingolipid catabolic process (GO:0046479) | 2.57119102 |
| 121 | collagen metabolic process (GO:0032963) | 2.56998902 |
| 122 | chondroitin sulfate catabolic process (GO:0030207) | 2.56311121 |
| 123 | germinal center formation (GO:0002467) | 2.56143688 |
| 124 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.54996123 |
| 125 | cell-cell junction maintenance (GO:0045217) | 2.54944090 |
| 126 | myeloid leukocyte activation (GO:0002274) | 2.54903448 |
| 127 | negative regulation of interleukin-17 production (GO:0032700) | 2.54832397 |
| 128 | cortical cytoskeleton organization (GO:0030865) | 2.54335962 |
| 129 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.52988125 |
| 130 | macrophage chemotaxis (GO:0048246) | 2.52480588 |
| 131 | focal adhesion assembly (GO:0048041) | 2.51201535 |
| 132 | cell-substrate adherens junction assembly (GO:0007045) | 2.51201535 |
| 133 | pentose-phosphate shunt (GO:0006098) | 2.50998355 |
| 134 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.50240803 |
| 135 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.49629040 |
| 136 | collagen catabolic process (GO:0030574) | 2.49204829 |
| 137 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.49159579 |
| 138 | regulation of macrophage cytokine production (GO:0010935) | 2.48760720 |
| 139 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.48372159 |
| 140 | regulation of mast cell degranulation (GO:0043304) | 2.48280260 |
| 141 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.47167439 |
| 142 | wound healing, spreading of cells (GO:0044319) | 2.46260314 |
| 143 | embryo implantation (GO:0007566) | 2.46047458 |
| 144 | extracellular matrix disassembly (GO:0022617) | 2.46017522 |
| 145 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.45558550 |
| 146 | regulation of cholesterol storage (GO:0010885) | 2.45202728 |
| 147 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.45057389 |
| 148 | positive regulation of extracellular matrix organization (GO:1903055) | 2.44623047 |
| 149 | positive regulation of interleukin-6 production (GO:0032755) | 2.43998246 |
| 150 | hypotonic response (GO:0006971) | 2.43841842 |
| 151 | positive regulation of interleukin-12 production (GO:0032735) | 2.42814253 |
| 152 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.42792964 |
| 153 | natural killer cell mediated immunity (GO:0002228) | 2.42792964 |
| 154 | monocyte chemotaxis (GO:0002548) | 2.42514613 |
| 155 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.42039819 |
| 156 | regulation of apoptotic cell clearance (GO:2000425) | 2.41453015 |
| 157 | cellular copper ion homeostasis (GO:0006878) | 2.41362376 |
| 158 | regulation of podosome assembly (GO:0071801) | 2.40838806 |
| 159 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.40740144 |
| 160 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.40666210 |
| 161 | neutrophil mediated immunity (GO:0002446) | 2.40127176 |
| 162 | cellular response to interferon-alpha (GO:0035457) | 2.38931027 |
| 163 | regulation of interferon-beta production (GO:0032648) | 2.38334059 |
| 164 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.38130199 |
| 165 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.36465267 |
| 166 | NADPH regeneration (GO:0006740) | 2.35709834 |
| 167 | negative regulation of interleukin-12 production (GO:0032695) | 2.35598785 |
| 168 | NIK/NF-kappaB signaling (GO:0038061) | 2.35439088 |
| 169 | positive regulation of p38MAPK cascade (GO:1900745) | 2.35354460 |
| 170 | iron ion import (GO:0097286) | 2.34654232 |
| 171 | positive regulation of phagocytosis (GO:0050766) | 2.34314711 |
| 172 | response to interferon-alpha (GO:0035455) | 2.34158808 |
| 173 | adenosine receptor signaling pathway (GO:0001973) | 2.33906615 |
| 174 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.33710053 |
| 175 | chondrocyte proliferation (GO:0035988) | 2.33647175 |
| 176 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.33080420 |
| 177 | amyloid precursor protein catabolic process (GO:0042987) | 2.32034162 |
| 178 | multicellular organismal catabolic process (GO:0044243) | 2.31985726 |
| 179 | multicellular organismal metabolic process (GO:0044236) | 2.30683990 |
| 180 | vesicle coating (GO:0006901) | 2.28709290 |
| 181 | gap junction assembly (GO:0016264) | 2.27995440 |
| 182 | actin filament bundle organization (GO:0061572) | 2.24575452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.59509700 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.67246798 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.42280008 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.40154249 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.25913868 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.96393720 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.76707915 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.69586969 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.36373771 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.32858510 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12230127 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.61057038 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56473060 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38163395 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.37748698 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32815009 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.30865998 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.28213056 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25895907 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.24317998 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.20732427 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.97844843 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.96175573 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.95274659 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.94994046 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.93904058 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.90475805 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87296494 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85658800 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.84442163 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.79162260 |
| 32 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.73865160 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71129131 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67549669 |
| 35 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.67289931 |
| 36 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.66427013 |
| 37 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.66427013 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66378568 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66231437 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.65636008 |
| 41 | TP53_16413492_ChIP-PET_HCT116_Human | 1.65253799 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62157736 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61871605 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59651819 |
| 45 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57660742 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57622464 |
| 47 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57028279 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56761693 |
| 49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.56567523 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55176663 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52122746 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.51280397 |
| 53 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.50728388 |
| 54 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49594947 |
| 55 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.48954941 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48738877 |
| 57 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.46558380 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.43787885 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42675555 |
| 60 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.42055458 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42027396 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.41690336 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 1.41343976 |
| 64 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41013990 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.40796312 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38208469 |
| 67 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.36296268 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.36254568 |
| 69 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.35404007 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35273201 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34174401 |
| 72 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.33936890 |
| 73 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33502613 |
| 74 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.30471058 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30108791 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28501993 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28501993 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28117532 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26964467 |
| 80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25893211 |
| 81 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25893211 |
| 82 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25560527 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25353631 |
| 84 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23329624 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22873145 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21368916 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21219977 |
| 88 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19625330 |
| 89 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.19068726 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18880890 |
| 91 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18504021 |
| 92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18407492 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17168423 |
| 94 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16380773 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15525670 |
| 96 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14913879 |
| 97 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13115179 |
| 98 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.12211869 |
| 99 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11197397 |
| 100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10671050 |
| 101 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08555879 |
| 102 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07496859 |
| 103 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07450316 |
| 104 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06882184 |
| 105 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05861485 |
| 106 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05817569 |
| 107 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05260944 |
| 108 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04746490 |
| 109 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04541374 |
| 110 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03824696 |
| 111 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02048409 |
| 112 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01882020 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01496925 |
| 114 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01173521 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01092629 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01018576 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00823157 |
| 118 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00585738 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00177617 |
| 120 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.99278486 |
| 121 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.99278486 |
| 122 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.99278486 |
| 123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98088538 |
| 124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97459819 |
| 125 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95118753 |
| 126 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95049368 |
| 127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94927446 |
| 128 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94845043 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94412843 |
| 130 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94240668 |
| 131 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93704002 |
| 132 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92771898 |
| 133 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92724795 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92406258 |
| 135 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.91967808 |
| 136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91511410 |
| 137 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.91425171 |
| 138 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90761085 |
| 139 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90690508 |
| 140 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90607990 |
| 141 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89958791 |
| 142 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89703492 |
| 143 | MYB_26560356_Chip-Seq_TH2_Human | 0.89261386 |
| 144 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89098105 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 0.89085091 |
| 146 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88646526 |
| 147 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88290424 |
| 148 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87240037 |
| 149 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85904053 |
| 150 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83823234 |
| 151 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82867676 |
| 152 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81833127 |
| 153 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.80253097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.65841546 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.18731842 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.06200734 |
| 4 | MP0006082_CNS_inflammation | 3.06043108 |
| 5 | MP0003303_peritoneal_inflammation | 3.00181643 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.93631495 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 2.70610063 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.69559520 |
| 9 | MP0003436_decreased_susceptibility_to | 2.67769104 |
| 10 | MP0002419_abnormal_innate_immunity | 2.54479341 |
| 11 | MP0002254_reproductive_system_inflammat | 2.34841857 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.26879560 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.18946874 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.17507699 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.15803782 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.14729723 |
| 17 | MP0003690_abnormal_glial_cell | 2.12910571 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.05216025 |
| 19 | MP0003075_altered_response_to | 2.04005066 |
| 20 | MP0003300_gastrointestinal_ulcer | 1.94245741 |
| 21 | MP0001533_abnormal_skeleton_physiology | 1.91838749 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.86277258 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.85337332 |
| 24 | MP0005451_abnormal_body_composition | 1.80435739 |
| 25 | MP0010307_abnormal_tumor_latency | 1.77343069 |
| 26 | MP0009785_altered_susceptibility_to | 1.76657171 |
| 27 | MP0003724_increased_susceptibility_to | 1.73681070 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.68895792 |
| 29 | MP0002796_impaired_skin_barrier | 1.67142297 |
| 30 | MP0002896_abnormal_bone_mineralization | 1.66608989 |
| 31 | MP0001958_emphysema | 1.66429001 |
| 32 | MP0000343_altered_response_to | 1.64366946 |
| 33 | MP0005409_darkened_coat_color | 1.64136121 |
| 34 | MP0005025_abnormal_response_to | 1.61984085 |
| 35 | MP0003279_aneurysm | 1.60325730 |
| 36 | MP0005023_abnormal_wound_healing | 1.59744902 |
| 37 | MP0003448_altered_tumor_morphology | 1.59672926 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.59427190 |
| 39 | MP0003045_fibrosis | 1.58842212 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.57904623 |
| 41 | MP0004510_myositis | 1.56195779 |
| 42 | MP0009278_abnormal_bone_marrow | 1.54905457 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.54540380 |
| 44 | MP0003329_amyloid_beta_deposits | 1.53883527 |
| 45 | MP0004947_skin_inflammation | 1.52819449 |
| 46 | MP0009384_cardiac_valve_regurgitation | 1.52480581 |
| 47 | MP0003091_abnormal_cell_migration | 1.52187822 |
| 48 | MP0005275_abnormal_skin_tensile | 1.50693967 |
| 49 | MP0005387_immune_system_phenotype | 1.48914199 |
| 50 | MP0001790_abnormal_immune_system | 1.48914199 |
| 51 | MP0000767_abnormal_smooth_muscle | 1.48778848 |
| 52 | MP0002723_abnormal_immune_serum | 1.44939562 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.41526624 |
| 54 | MP0001915_intracranial_hemorrhage | 1.40151669 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.39771932 |
| 56 | MP0003828_pulmonary_edema | 1.38766769 |
| 57 | MP0001819_abnormal_immune_cell | 1.38215909 |
| 58 | MP0004883_abnormal_blood_vessel | 1.38013727 |
| 59 | MP0001800_abnormal_humoral_immune | 1.37362893 |
| 60 | MP0004272_abnormal_basement_membrane | 1.35842619 |
| 61 | MP0000685_abnormal_immune_system | 1.35721033 |
| 62 | MP0005671_abnormal_response_to | 1.34890062 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 1.34793781 |
| 64 | MP0004233_abnormal_muscle_weight | 1.34546040 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.33307885 |
| 66 | MP0005164_abnormal_response_to | 1.31957572 |
| 67 | MP0005166_decreased_susceptibility_to | 1.31017923 |
| 68 | MP0008260_abnormal_autophagy | 1.29964572 |
| 69 | MP0000537_abnormal_urethra_morphology | 1.28449810 |
| 70 | MP0000858_altered_metastatic_potential | 1.25758857 |
| 71 | MP0003941_abnormal_skin_development | 1.24397077 |
| 72 | MP0005390_skeleton_phenotype | 1.21538178 |
| 73 | MP0002006_tumorigenesis | 1.19803771 |
| 74 | MP0009840_abnormal_foam_cell | 1.18207245 |
| 75 | MP0001216_abnormal_epidermal_layer | 1.14359795 |
| 76 | MP0010030_abnormal_orbit_morphology | 1.14311739 |
| 77 | MP0009053_abnormal_anal_canal | 1.14285331 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.12229625 |
| 79 | MP0005171_absent_coat_pigmentation | 1.11800318 |
| 80 | MP0005501_abnormal_skin_physiology | 1.11079165 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.10831841 |
| 82 | MP0001853_heart_inflammation | 1.10522142 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.09852383 |
| 84 | MP0000249_abnormal_blood_vessel | 1.08281480 |
| 85 | MP0001851_eye_inflammation | 1.07654332 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 1.07320931 |
| 87 | MP0006054_spinal_hemorrhage | 1.06537580 |
| 88 | MP0000604_amyloidosis | 1.06350352 |
| 89 | MP0000733_abnormal_muscle_development | 1.05763450 |
| 90 | MP0005248_abnormal_Harderian_gland | 1.04338538 |
| 91 | MP0004858_abnormal_nervous_system | 1.04193543 |
| 92 | MP0004264_abnormal_extraembryonic_tissu | 1.03020878 |
| 93 | MP0008469_abnormal_protein_level | 1.02331518 |
| 94 | MP0002405_respiratory_system_inflammati | 1.01837911 |
| 95 | MP0001542_abnormal_bone_strength | 1.01563655 |
| 96 | MP0005595_abnormal_vascular_smooth | 1.00760816 |
| 97 | MP0005508_abnormal_skeleton_morphology | 0.98455635 |
| 98 | MP0003634_abnormal_glial_cell | 0.96616136 |
| 99 | MP0002933_joint_inflammation | 0.96110787 |
| 100 | MP0000579_abnormal_nail_morphology | 0.95940424 |
| 101 | MP0002098_abnormal_vibrissa_morphology | 0.95322844 |
| 102 | MP0003950_abnormal_plasma_membrane | 0.94221913 |
| 103 | MP0010155_abnormal_intestine_physiology | 0.93001385 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.92940747 |
| 105 | MP0001545_abnormal_hematopoietic_system | 0.92940747 |
| 106 | MP0008007_abnormal_cellular_replicative | 0.92345269 |
| 107 | MP0008004_abnormal_stomach_pH | 0.92290595 |
| 108 | MP0000371_diluted_coat_color | 0.89907709 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.88498332 |
| 110 | MP0002168_other_aberrant_phenotype | 0.88244291 |
| 111 | MP0003795_abnormal_bone_structure | 0.87898610 |
| 112 | MP0005623_abnormal_meninges_morphology | 0.87848522 |
| 113 | MP0005197_abnormal_uvea_morphology | 0.87754749 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.87642992 |
| 115 | MP0002060_abnormal_skin_morphology | 0.86199942 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.86082632 |
| 117 | MP0009764_decreased_sensitivity_to | 0.85580718 |
| 118 | MP0004808_abnormal_hematopoietic_stem | 0.85001262 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.84891603 |
| 120 | MP0000383_abnormal_hair_follicle | 0.84803407 |
| 121 | MP0001243_abnormal_dermal_layer | 0.84467297 |
| 122 | MP0000716_abnormal_immune_system | 0.82147269 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.81457293 |
| 124 | MP0002277_abnormal_respiratory_mucosa | 0.81248495 |
| 125 | MP0001849_ear_inflammation | 0.79593706 |
| 126 | MP0005165_increased_susceptibility_to | 0.78549561 |
| 127 | MP0000377_abnormal_hair_follicle | 0.76263557 |
| 128 | MP0000920_abnormal_myelination | 0.75550023 |
| 129 | MP0005310_abnormal_salivary_gland | 0.75069494 |
| 130 | MP0005621_abnormal_cell_physiology | 0.74628643 |
| 131 | MP0000627_abnormal_mammary_gland | 0.74498252 |
| 132 | MP0009333_abnormal_splenocyte_physiolog | 0.74445118 |
| 133 | MP0000762_abnormal_tongue_morphology | 0.73100896 |
| 134 | MP0000467_abnormal_esophagus_morphology | 0.70665358 |
| 135 | MP0001614_abnormal_blood_vessel | 0.70260843 |
| 136 | MP0005193_abnormal_anterior_eye | 0.69808838 |
| 137 | MP0002089_abnormal_postnatal_growth/wei | 0.68396575 |
| 138 | MP0000747_muscle_weakness | 0.67345408 |
| 139 | MP0005375_adipose_tissue_phenotype | 0.67166372 |
| 140 | MP0002092_abnormal_eye_morphology | 0.67144867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.11589065 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.74261750 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.41994743 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.23209860 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.13186327 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.94617906 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.94617906 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.94617906 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.77111875 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.59350505 |
| 11 | Glomerulonephritis (HP:0000099) | 3.50073857 |
| 12 | Arterial tortuosity (HP:0005116) | 3.44149653 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.44113455 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.39416555 |
| 15 | Cervical subluxation (HP:0003308) | 3.31969577 |
| 16 | Hematochezia (HP:0002573) | 3.24546702 |
| 17 | Cerebral aneurysm (HP:0004944) | 3.21820435 |
| 18 | Vascular tortuosity (HP:0004948) | 3.15757171 |
| 19 | Thick nail (HP:0001805) | 3.13407635 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.04142968 |
| 21 | Mucopolysacchariduria (HP:0008155) | 3.04142968 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.01948809 |
| 23 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.96545041 |
| 24 | Osteolytic defects of the hand bones (HP:0009699) | 2.96545041 |
| 25 | Prostate neoplasm (HP:0100787) | 2.95434706 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.93531348 |
| 27 | Spondylolisthesis (HP:0003302) | 2.91772503 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.89831401 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.89831401 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.89831401 |
| 31 | Disinhibition (HP:0000734) | 2.84755674 |
| 32 | J-shaped sella turcica (HP:0002680) | 2.83592491 |
| 33 | Hyperacusis (HP:0010780) | 2.76225256 |
| 34 | Aortic aneurysm (HP:0004942) | 2.71269995 |
| 35 | Nephritis (HP:0000123) | 2.70584169 |
| 36 | Myocardial infarction (HP:0001658) | 2.66426842 |
| 37 | Abnormality of complement system (HP:0005339) | 2.63528636 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.62956453 |
| 39 | Aortic dissection (HP:0002647) | 2.61715791 |
| 40 | Agnosia (HP:0010524) | 2.61528041 |
| 41 | Natal tooth (HP:0000695) | 2.59561696 |
| 42 | Nuclear cataract (HP:0100018) | 2.58870474 |
| 43 | Urethral obstruction (HP:0000796) | 2.57740164 |
| 44 | Short nail (HP:0001799) | 2.57599588 |
| 45 | Orchitis (HP:0100796) | 2.56395746 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.55255355 |
| 47 | Premature rupture of membranes (HP:0001788) | 2.54423886 |
| 48 | Gingivitis (HP:0000230) | 2.53781064 |
| 49 | Myositis (HP:0100614) | 2.46028996 |
| 50 | Absent frontal sinuses (HP:0002688) | 2.45576642 |
| 51 | Flat acetabular roof (HP:0003180) | 2.42823059 |
| 52 | Axonal loss (HP:0003447) | 2.42328080 |
| 53 | Thin bony cortex (HP:0002753) | 2.38054079 |
| 54 | Protrusio acetabuli (HP:0003179) | 2.35848063 |
| 55 | Periodontitis (HP:0000704) | 2.34780145 |
| 56 | Complement deficiency (HP:0004431) | 2.31913631 |
| 57 | Deformed sella turcica (HP:0002681) | 2.28163458 |
| 58 | Increased connective tissue (HP:0009025) | 2.21986890 |
| 59 | Fragile skin (HP:0001030) | 2.21932818 |
| 60 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.21339677 |
| 61 | Distal lower limb amyotrophy (HP:0008944) | 2.21105641 |
| 62 | Optic neuritis (HP:0100653) | 2.18214731 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.18214731 |
| 64 | Recurrent skin infections (HP:0001581) | 2.17296676 |
| 65 | Distal lower limb muscle weakness (HP:0009053) | 2.15809447 |
| 66 | Spinal cord lesions (HP:0100561) | 2.14946571 |
| 67 | Syringomyelia (HP:0003396) | 2.14946571 |
| 68 | Bladder diverticulum (HP:0000015) | 2.12379175 |
| 69 | Autoimmune thrombocytopenia (HP:0001973) | 2.10252672 |
| 70 | Achilles tendon contracture (HP:0001771) | 2.06519175 |
| 71 | Ankle contracture (HP:0006466) | 2.05602317 |
| 72 | Spinal rigidity (HP:0003306) | 2.04897606 |
| 73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04364323 |
| 74 | Obstructive lung disease (HP:0006536) | 2.04364323 |
| 75 | Wormian bones (HP:0002645) | 2.03918766 |
| 76 | Advanced eruption of teeth (HP:0006288) | 2.03056773 |
| 77 | Blue sclerae (HP:0000592) | 2.02481444 |
| 78 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01718628 |
| 79 | Basal ganglia calcification (HP:0002135) | 1.99628354 |
| 80 | Broad face (HP:0000283) | 1.99593099 |
| 81 | Ulnar bowing (HP:0003031) | 1.99261962 |
| 82 | Shallow orbits (HP:0000586) | 1.97748118 |
| 83 | Biconcave vertebral bodies (HP:0004586) | 1.96801038 |
| 84 | Mitral valve prolapse (HP:0001634) | 1.95079294 |
| 85 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.94310961 |
| 86 | Interstitial pulmonary disease (HP:0006530) | 1.94022609 |
| 87 | Mitral stenosis (HP:0001718) | 1.93561314 |
| 88 | Pathologic fracture (HP:0002756) | 1.93333978 |
| 89 | Diminished motivation (HP:0000745) | 1.91610026 |
| 90 | Arterial thrombosis (HP:0004420) | 1.90576613 |
| 91 | Vertebral compression fractures (HP:0002953) | 1.90512905 |
| 92 | Abnormality of the frontal sinuses (HP:0002687) | 1.90013531 |
| 93 | Tetraparesis (HP:0002273) | 1.89999324 |
| 94 | Distal upper limb amyotrophy (HP:0007149) | 1.89650447 |
| 95 | Upper limb amyotrophy (HP:0009129) | 1.89650447 |
| 96 | Hepatosplenomegaly (HP:0001433) | 1.85761531 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 1.84836116 |
| 98 | Dilatation of the ascending aorta (HP:0005111) | 1.82633154 |
| 99 | Atrophic scars (HP:0001075) | 1.81910580 |
| 100 | Osteomyelitis (HP:0002754) | 1.80315377 |
| 101 | Aneurysm (HP:0002617) | 1.79441935 |
| 102 | Upper motor neuron abnormality (HP:0002127) | 1.79283602 |
| 103 | Abnormality of the acetabulum (HP:0003170) | 1.78657305 |
| 104 | Abnormality of dentin (HP:0010299) | 1.78567706 |
| 105 | Peritonitis (HP:0002586) | 1.78099656 |
| 106 | Abnormality of the thoracic spine (HP:0100711) | 1.77858238 |
| 107 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.77367070 |
| 108 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.76607945 |
| 109 | Retinal atrophy (HP:0001105) | 1.75220931 |
| 110 | Pustule (HP:0200039) | 1.74826970 |
| 111 | Mitral regurgitation (HP:0001653) | 1.73441418 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.73197654 |
| 113 | Long toe (HP:0010511) | 1.72827223 |
| 114 | Abnormality of the sella turcica (HP:0002679) | 1.71767010 |
| 115 | Abnormality of the lumbar spine (HP:0100712) | 1.71468490 |
| 116 | Premature loss of primary teeth (HP:0006323) | 1.70914256 |
| 117 | Soft skin (HP:0000977) | 1.70695092 |
| 118 | Cellulitis (HP:0100658) | 1.70598619 |
| 119 | Recurrent fungal infections (HP:0002841) | 1.69850842 |
| 120 | Neonatal short-limb short stature (HP:0008921) | 1.68769599 |
| 121 | Stomatitis (HP:0010280) | 1.66875998 |
| 122 | Insomnia (HP:0100785) | 1.65898140 |
| 123 | Protuberant abdomen (HP:0001538) | 1.65653689 |
| 124 | Skin nodule (HP:0200036) | 1.64754371 |
| 125 | Coarse hair (HP:0002208) | 1.63999184 |
| 126 | Striae distensae (HP:0001065) | 1.63170242 |
| 127 | Bone pain (HP:0002653) | 1.62052305 |
| 128 | Abnormal ossification of hand bones (HP:0005921) | 1.61036645 |
| 129 | Genu recurvatum (HP:0002816) | 1.61024878 |
| 130 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.60027480 |
| 131 | Asymmetric septal hypertrophy (HP:0001670) | 1.59816654 |
| 132 | Joint stiffness (HP:0001387) | 1.59677771 |
| 133 | Esophageal varix (HP:0002040) | 1.59537525 |
| 134 | Multiple lipomas (HP:0001012) | 1.59445106 |
| 135 | Neonatal death (HP:0003811) | 1.58539013 |
| 136 | Keratoconjunctivitis sicca (HP:0001097) | 1.58124867 |
| 137 | Broad metatarsal (HP:0001783) | 1.57465428 |
| 138 | Ovoid vertebral bodies (HP:0003300) | 1.57282906 |
| 139 | Thoracic kyphosis (HP:0002942) | 1.56545419 |
| 140 | Disproportionate tall stature (HP:0001519) | 1.55453686 |
| 141 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.54446505 |
| 142 | Abnormality of the peritoneum (HP:0002585) | 1.53824858 |
| 143 | Loss of speech (HP:0002371) | 1.52627221 |
| 144 | Apathy (HP:0000741) | 1.51595198 |
| 145 | Abnormality of the odontoid process (HP:0003310) | 1.50226099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.36083070 |
| 2 | RIPK4 | 2.78143075 |
| 3 | MAP3K14 | 2.77620846 |
| 4 | TYK2 | 2.76015621 |
| 5 | BLK | 2.56728605 |
| 6 | NME2 | 2.42596925 |
| 7 | STK10 | 2.39914071 |
| 8 | IRAK3 | 2.39163154 |
| 9 | NEK9 | 2.17338458 |
| 10 | TBK1 | 2.16788736 |
| 11 | SMG1 | 2.14552908 |
| 12 | IRAK4 | 2.08649904 |
| 13 | GRK7 | 2.03527828 |
| 14 | EPHB2 | 2.03286645 |
| 15 | CSF1R | 2.02524950 |
| 16 | KIT | 1.99846370 |
| 17 | LATS2 | 1.97415636 |
| 18 | ICK | 1.96349725 |
| 19 | EEF2K | 1.92878271 |
| 20 | MOS | 1.87313668 |
| 21 | TTN | 1.84973944 |
| 22 | CAMK1D | 1.80950439 |
| 23 | PAK4 | 1.77354907 |
| 24 | JAK1 | 1.76486479 |
| 25 | TRIB3 | 1.64534980 |
| 26 | PRPF4B | 1.56984511 |
| 27 | PKN2 | 1.54309109 |
| 28 | IKBKB | 1.52627129 |
| 29 | JAK3 | 1.51147272 |
| 30 | TESK1 | 1.45967133 |
| 31 | ERN1 | 1.45416199 |
| 32 | CSK | 1.43680549 |
| 33 | LMTK2 | 1.42296591 |
| 34 | PTK6 | 1.41616354 |
| 35 | NTRK1 | 1.37559210 |
| 36 | MATK | 1.35900692 |
| 37 | MAP2K3 | 1.29888836 |
| 38 | CDC42BPA | 1.29350357 |
| 39 | RPS6KA4 | 1.25912951 |
| 40 | FGFR3 | 1.25704846 |
| 41 | MAP3K3 | 1.23814497 |
| 42 | CDK6 | 1.23633030 |
| 43 | FGR | 1.22880703 |
| 44 | CHUK | 1.20943597 |
| 45 | HCK | 1.19928646 |
| 46 | TRPM7 | 1.19657310 |
| 47 | IKBKE | 1.18903778 |
| 48 | LATS1 | 1.18777927 |
| 49 | BMX | 1.12599395 |
| 50 | MAP3K13 | 1.11144370 |
| 51 | DDR2 | 1.09113703 |
| 52 | RIPK1 | 1.08824134 |
| 53 | LIMK1 | 1.07901277 |
| 54 | TAOK2 | 1.07876202 |
| 55 | ERBB4 | 1.07231628 |
| 56 | PIM2 | 1.04966342 |
| 57 | EIF2AK2 | 1.02633099 |
| 58 | EPHA2 | 1.01792160 |
| 59 | PDGFRA | 1.01546304 |
| 60 | MTOR | 1.00815407 |
| 61 | ARAF | 1.00262560 |
| 62 | STK3 | 1.00006599 |
| 63 | ABL2 | 0.98784019 |
| 64 | SCYL2 | 0.98224025 |
| 65 | CAMK1G | 0.97539562 |
| 66 | JAK2 | 0.94118418 |
| 67 | EPHB1 | 0.90497916 |
| 68 | CDK12 | 0.88058561 |
| 69 | RPS6KA2 | 0.86544999 |
| 70 | FGFR4 | 0.83584315 |
| 71 | EPHA3 | 0.83090679 |
| 72 | PBK | 0.82826787 |
| 73 | CLK1 | 0.81492120 |
| 74 | LYN | 0.81351317 |
| 75 | MYLK | 0.81286702 |
| 76 | FER | 0.79482465 |
| 77 | MAP3K6 | 0.79097726 |
| 78 | PRKG2 | 0.78641076 |
| 79 | MST1R | 0.77678753 |
| 80 | PRKD2 | 0.74465518 |
| 81 | NUAK1 | 0.74076802 |
| 82 | ERBB3 | 0.72312012 |
| 83 | EGFR | 0.71582180 |
| 84 | TGFBR1 | 0.70673851 |
| 85 | YES1 | 0.70527641 |
| 86 | LCK | 0.70401386 |
| 87 | KSR2 | 0.68154563 |
| 88 | IGF1R | 0.67017089 |
| 89 | DMPK | 0.66770187 |
| 90 | PAK2 | 0.65360545 |
| 91 | FES | 0.65102018 |
| 92 | MAP3K8 | 0.63162203 |
| 93 | PDPK1 | 0.62599017 |
| 94 | ROCK2 | 0.61670301 |
| 95 | PLK2 | 0.60799345 |
| 96 | MARK3 | 0.59697623 |
| 97 | MAPK7 | 0.58835662 |
| 98 | BMPR2 | 0.58834944 |
| 99 | PTK2B | 0.57874394 |
| 100 | MAPKAPK2 | 0.57645671 |
| 101 | PDGFRB | 0.57528979 |
| 102 | FRK | 0.56171961 |
| 103 | ABL1 | 0.54341890 |
| 104 | CDK8 | 0.54140865 |
| 105 | TESK2 | 0.53817902 |
| 106 | CAMKK1 | 0.53661402 |
| 107 | MAP3K1 | 0.52919462 |
| 108 | ZAP70 | 0.52577786 |
| 109 | MAP4K1 | 0.51993496 |
| 110 | PTK2 | 0.50948329 |
| 111 | PDK2 | 0.48754770 |
| 112 | GSK3A | 0.48136114 |
| 113 | LRRK2 | 0.48060480 |
| 114 | MAPK15 | 0.47939922 |
| 115 | RET | 0.47750843 |
| 116 | PRKCD | 0.47622595 |
| 117 | PIM1 | 0.47333311 |
| 118 | INSR | 0.47108854 |
| 119 | MAP3K2 | 0.46356567 |
| 120 | MAP3K10 | 0.45123472 |
| 121 | CDK9 | 0.45043564 |
| 122 | MARK2 | 0.43611438 |
| 123 | RPS6KC1 | 0.42518673 |
| 124 | RPS6KL1 | 0.42518673 |
| 125 | TAOK1 | 0.42111790 |
| 126 | KSR1 | 0.41280837 |
| 127 | MELK | 0.41033130 |
| 128 | MET | 0.40767086 |
| 129 | PRKD3 | 0.40636265 |
| 130 | SGK3 | 0.40281021 |
| 131 | IRAK2 | 0.39224142 |
| 132 | ILK | 0.38291375 |
| 133 | BTK | 0.37829884 |
| 134 | ERBB2 | 0.37141992 |
| 135 | SRC | 0.37015490 |
| 136 | SIK1 | 0.36216551 |
| 137 | ITK | 0.34095917 |
| 138 | FLT3 | 0.34078586 |
| 139 | ROCK1 | 0.33908854 |
| 140 | TEC | 0.31791963 |
| 141 | STK24 | 0.30297840 |
| 142 | CAMK2G | 0.28754990 |
| 143 | DAPK3 | 0.28546715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.24145879 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.09309463 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.77000078 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.30117535 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.25435786 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23123475 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.18136466 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.08336323 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.07197595 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.83730529 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.82332360 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70565758 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69163622 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.68247620 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66346388 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.65340989 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.61050438 |
| 18 | Salmonella infection_Homo sapiens_hsa05132 | 1.56318644 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.56091512 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.49462070 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.46135078 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44825936 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.44556285 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.41542711 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41334550 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.40251414 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.39933956 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38990856 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.36568098 |
| 30 | Adherens junction_Homo sapiens_hsa04520 | 1.34103249 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.33872726 |
| 32 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.31122024 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.28615608 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27898904 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27473750 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.25772971 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24776919 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21890496 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.20682482 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20357939 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19016810 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18285650 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16877218 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14367284 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12506513 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.09555235 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 1.08344765 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.07589669 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.05395170 |
| 50 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.05050955 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04271446 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03046420 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02934146 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 1.02849663 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01531658 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00075146 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97880373 |
| 58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97764191 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96933372 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96603640 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.96434287 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94850030 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94695143 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91186132 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.90758994 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90129927 |
| 67 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.89380929 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.89208179 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87468092 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84438993 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80407891 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79430030 |
| 73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79227828 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78634010 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77605190 |
| 76 | Allograft rejection_Homo sapiens_hsa05330 | 0.77543852 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74292597 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71129579 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70509458 |
| 80 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70065179 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69901837 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68031099 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67564091 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67320311 |
| 85 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66832571 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65691995 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65607105 |
| 88 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64436982 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64185841 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.63598224 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.62917762 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.62798978 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61493340 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61097506 |
| 95 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60795480 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.60637149 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59841598 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.59717727 |
| 99 | Melanoma_Homo sapiens_hsa05218 | 0.59455408 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58424413 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.58132046 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58058225 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58045415 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57508194 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57155029 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56439922 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56342356 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56121480 |
| 109 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55966428 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55561238 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53987067 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53784174 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53592187 |
| 114 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52179138 |
| 115 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50770853 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50760996 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49269382 |
| 118 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48476596 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47961058 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47916479 |
| 121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46593296 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46150197 |
| 123 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44315567 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43477024 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42403355 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.42206373 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.41487450 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40773265 |
| 129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40589939 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40530661 |
| 131 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40349931 |
| 132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.39090734 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38429893 |
| 134 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.37290434 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37273479 |

